Friday 6 November 2026 Export ELAN’s income statement to Excel — free account

Elanco Animal Health Incorporated

ELAN Healthcare Drug Manufacturers Specialty & Generic

Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.

Revenue: +10.2%
EPS: +450.0%
Free cash flow: +35.6%
Total debt: −6.91%

Quarter to June 2026, against a year earlier

23.74 1.57 −6.20%

Follow ELAN

Alert me

Market cap: $11.8B
P/E: 0.0×
Fwd P/E: 161×
Dividend yield: —
F-score: 5/9
Altman Z: 1.28
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Elanco Animal Health Incorporated (ELAN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Elanco Animal Health Incorporated (ELAN) trades at a P/B ratio of 1.8×. Over the past ten years it has ranged from 0.5× (May 2023) to 2.4× (June 2019); the current reading is higher than 70% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 1.8× and below the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ELAN/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Elanco Animal Health Incorporated P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ELAN/metrics/pb-ratio">Elanco Animal Health Incorporated (ELAN) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.7×	74.83%
FY2024	1.0×	(15.27%)
FY2023	1.2×	40.00%
FY2022	0.8×	(55.08%)
FY2021	1.8×	15.30%
FY2020	1.6×	(18.47%)
FY2019	2.0×	2.95%
FY2018	1.9×	26.66%
FY2017	1.5×	0.00%
FY2016	1.5×	0.00%

Period	P/B ratio	Change
Jun 2026	1.9×	1.83%
Mar 2026	1.8×	6.79%
Dec 2025	1.7×	15.74%
Sep 2025	1.5×	41.64%
31 more quarters	Free account

Against its own ten years

Low 0.5× High 2.4×

Ten-year median 1.6×

Current reading's percentile 70

Company	P/B ratio
VTRS Viatris Inc. compare	1.6×
ELAN Elanco Animal Health Incorporated	1.8×
RDY Dr. Reddy's Laboratories Ltd compare	3.0×
ALKS Alkermes plc compare	4.0×
NBIX Neurocrine Biosciences, Inc. compare	4.2×
LNTH Lantheus Holdings, Inc. compare	4.9×
KNSA Kiniksa Pharmaceuticals International, plc compare	9.7×
HIMS Hims & Hers Health, Inc. compare	17.2×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	59.5×
Drug Manufacturers Specialty & Generic industry median	1.8×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Elanco Animal Health Incorporated (ELAN) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ELAN

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ELAN

Stockrow Weekly